Skip to main content
Jeffrey Miller, MD, Oncology, Sylmar, CA

JeffreyMillerMD

Oncology Sylmar, CA

Hematologic Oncology, Hospice & Palliative

Ass prof medicine

Dr. Miller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Miller's full profile

Already have an account?

  • Office

    14445 Olive View Dr
    Dept Of Medicine 2b-182
    Sylmar, CA 91342
    Phone+1 818-364-3205

Education & Training

  • University of Maryland
    University of MarylandFellowship, Hematology and Medical Oncology, 1991 - 1994
  • Rutgers Health/New Jersey Medical School
    Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 1988 - 1991
  • Ross University School of Medicine
    Ross University School of MedicineClass of 1988

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2004 - 2019
  • ME State Medical License
    ME State Medical License 1994 - 2013
  • National Board of Physicians and Surgeons Hematology
  • National Board of Physicians and Surgeons Hospice and Palliative Medicine
  • National Board of Physicians and Surgeons Internal Medicine
  • National Board of Physicians and Surgeons Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Invivoscribe Files sPMA with the FDA for Use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AML
    Invivoscribe Files sPMA with the FDA for Use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AMLOctober 24th, 2022
  • The Society for Immunotherapy of Cancer (SITC) Invites You to Attend the Virtual Press Briefing of the Society’s 36th Anniversary Annual Meeting
    The Society for Immunotherapy of Cancer (SITC) Invites You to Attend the Virtual Press Briefing of the Society’s 36th Anniversary Annual MeetingNovember 2nd, 2021
  • GT Biopharma Provides Second Quarter 2021 Business Update
    GT Biopharma Provides Second Quarter 2021 Business UpdateAugust 13th, 2021
  • Join now to see all